Friday, December 02, 2005 4:25:47 AM
NEKTAR (NKTR): This is essentially an inhalable insulin company and final FDA approval for Exubera, its product (marketed by Pfizer), is on the very near-term horizon.
* Recent Trends: Trading is all over the place and there is no clear trend in the stock.
* Upside Catalysts: An FDA approval is being taken more and more for granted, and may even prompt a sell-off in the stock, which happened when Amylin's Byetta was approved by the FDA. Assuming Exubera is available for sale for at least three months in the first half of 2006, that preliminary sales data will drive the stock.
* Downside Catalysts: An FDA rejection would be a total disaster. Should the FDA give a qualified approval with a narrow label (this would restrict the marketing of the product) that will hurt the stock and create a buying opportunity, because ChangeWave Alliance surveys show the product will be sell very well even with narrow FDA approval.
http://www.changewave.com/biotech/
Recent NKTR News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:20:50 PM
- Nektar Therapeutics Reports First Quarter 2024 Financial Results • PR Newswire (US) • 05/09/2024 08:15:00 PM
- Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets • PR Newswire (US) • 05/02/2024 10:00:00 PM
- Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference • PR Newswire (US) • 03/22/2024 06:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 10:11:03 PM
- Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata • PR Newswire (US) • 03/05/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:20:46 PM
- Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results • PR Newswire (US) • 03/04/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 01:40:59 PM
- Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX • PR Newswire (US) • 03/04/2024 01:30:00 PM
- Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference • PR Newswire (US) • 02/27/2024 11:00:00 PM
- Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Markets • PR Newswire (US) • 02/26/2024 11:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 01:19:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 01:17:52 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 01:16:48 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 08:55:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 08:51:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 08:50:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:16:10 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 10:03:19 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:50:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:25:25 PM
- Nektar Management To Present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA • PR Newswire (US) • 01/03/2024 11:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:07:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:05:59 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM